ConductScience.org, home

Paper36958764

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1.

Hoang HD and 15 others. J Immunother Cancer, 2023. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Papers, record 36958764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958764

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2023-03-31
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoang HDHuy-Dung
2Said AAida
3Vaidya NNasana
4Gilchrist VHVictoria H
5Malone KKyle
6Kabilan UUsha
7Topshee SSerena
8Xiang XXiao
9Yang ADAn-Dao
10Olagnier DDavid
11Mossman KKaren
12Beug STShawn T
13Jafarnejad SMSeyed Mehdi
14Workenhe STSamuel Thttps://orcid.org/0000-0001-9521-3903
15Graber TETyson E
16Alain TTommyhttps://orcid.org/0000-0002-0396-9138

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpesvirus 1, HumanMajor topic
Oncolytic VirusesMajor topic
Animals
Mice
Granulocyte-Macrophage Colony-Stimulating Factor
Transgenes
Protein Biosynthesis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CIHRCanadaPubMed

Source PubMed

Download CSV of grants

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11313912Effect of genomic location on expression of beta-galactosidase mRNA controlled by the herpes simplex virus type 1 UL38 promoter.J Virol1992https://conductscience.org/library/papers/1313912PubMed
230997392Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors.Mol Ther Oncolytics2019https://conductscience.org/library/papers/30997392PubMed
321886163Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.Nature2011https://conductscience.org/library/papers/21886163PubMed
426436135Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children.Mol Ther Oncolytics2015https://conductscience.org/library/papers/26436135PubMed
515003868Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.Virology2004https://conductscience.org/library/papers/15003868PubMed
617383529Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.Surgery2007https://conductscience.org/library/papers/17383529PubMed
718846111hnRNP A1 regulates UV-induced NF-kappaB signalling through destabilization of cIAP1 mRNA.Cell Death Differ2009https://conductscience.org/library/papers/18846111PubMed
88892862The RGG box motif of the herpes simplex virus ICP27 protein mediates an RNA-binding activity and determines in vivo methylation.J Virol1996https://conductscience.org/library/papers/8892862PubMed
922595793Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.Cancer Gene Ther2012https://conductscience.org/library/papers/22595793PubMed
1012595888ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.Gene Ther2003https://conductscience.org/library/papers/12595888PubMed
1121602908High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice.PLoS One2011https://conductscience.org/library/papers/21602908PubMed
1235864254Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med2022https://conductscience.org/library/papers/35864254PubMed
131846210Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene.J Virol1991https://conductscience.org/library/papers/1846210PubMed
1411020347Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.Mol Ther2000https://conductscience.org/library/papers/11020347PubMed
1531206552Hidden regulation of herpes simplex virus 1 pre-mRNA splicing and polyadenylation by virally encoded immediate early gene ICP27.PLoS Pathog2019https://conductscience.org/library/papers/31206552PubMed
1629746850Battling for Ribosomes: Translational Control at the Forefront of the Antiviral Response.J Mol Biol2018https://conductscience.org/library/papers/29746850PubMed
1720436464Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.Nat Biotechnol2010https://conductscience.org/library/papers/20436464PubMed
1816300675Functional inaccessibility of quiescent herpes simplex virus genomes.Virol J2005https://conductscience.org/library/papers/16300675PubMed
1928676792Long-Read Isoform Sequencing Reveals a Hidden Complexity of the Transcriptional Landscape of Herpes Simplex Virus Type 1.Front Microbiol2017https://conductscience.org/library/papers/28676792PubMed
2029790989The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update.Nucleic Acids Res2018https://conductscience.org/library/papers/29790989PubMed

See all 53 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42580805HSV-1 metabolic hijacking: Mechanisms to precision therapeutics.Virulence2026https://conductscience.org/library/papers/42580805PubMed
40352942Oncolytic viruses: a promising therapy for malignant pleural effusion and solid tumors.Front Immunol2025https://conductscience.org/library/papers/40352942PubMed
38325225The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study.ESMO Open2024https://conductscience.org/library/papers/38325225PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36958764

GET https://conductscience.org/api/papers/v1/36958764/references?page=2